Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Behind every facility expansion, technology investment, and quality milestone in the CDMO sector is a leadership team making deliberate choices about where to focus, how to grow, and when to take calculated risks.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
A video roundup of the week’s top industry news stories.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A one-on-one video interview between our editorial teams and industry leaders.
Listen to expert discussions and interviews in pharma and biopharma.
Contract Pharma Stream offers a centralized destination where users can watch expert-led sessions anytime, anywhere
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
The appointments impact Ardena’s financial strategy as well as business development and marketing.
May 4, 2026
By: Patrick Lavery
Content Marketing Editor
Ardena is appointing Ben Ash as Chief Financial Officer (CFO) and Henny Zijlstra as Chief Commercial Officer (CCO). The company is a specialist pharmaceutical CDMO and bioanalytical contract research organization (CRO) for precision medicines and other complex therapies.
According to Ardena, the executive team additions come as the company is trying to globally scale operations and commercial reach.
“Over the past 15 months, Ardena has undergone a significant transformation,” said Ardena CEO Jeremie Trochu. This includes United States expansion, divestment of operations in Sweden, and investing in bioanalytical services, nanomedicines, and digital capacity.
“As we move into the next phase, Ben and Henny bring the drive, focus, and leadership needed,” Trochu said. “Their experience will be critical as we continue to build a more focused, innovative, and international Ardena.”
Ash will lead Ardena’s financial strategy, supporting a scalable level of growth that includes disciplined international expansion. Additionally, he will work with the company’s Chief Information Officer on advancing Ardena’s roadmap to digitization.
Most recently, Ash was CFO at Essential Pharma. He previously held senior finance roles at PTC Therapeutics and Shire.
Zijlstra is set to guide Ardena’s commercial organization across business development and marketing. She is being tasked with elevating the company’s brand presence and accelerating its go-to-market strategy. Ardena says these improvements will broaden its customer engagement and bring further visibility to the company’s drug development capabilities.
Previously, Zijlstra occupied senior leadership roles at Adragos and Lonza.
“Ardena has a very strong operational foundation and a uniquely differentiated scientific offering,” Ash said. “I am very excited to join the company, and I look forward to supporting its next phase of international growth.”
“I am energized by the opportunity to work with Ardena’s talented subject matter experts,” Zijlstra said. She added she hopes to “bring the company’s capabilities to the market with clarity and impact, while building deep relationships.”
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !